Related Experiment Video
Updated: Aug 8, 2026

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
[A monoclonal antibody reactive with human squamous cell carcinoma of the esophagus]
1First Department of Surgery, Kurume University School of Medicine, Japan.
Monoclonal antibody KYSM-1, whose immunoglobulin was IgM, was produced against human esophageal squamous cell carcinoma (KE-1) which has been maintained by serial subcutaneous transplantation in nude mice. In immunohistochemical reactions with various cancer tissues, KYSM-1 showed a strong reaction specific to squamous cell carcinomas of the esophagus, oral cavity and lung (92%, 95/103 and 100%, 3/3 and 100%, 7/7), with the lack of gastrointestinal adenocarcinomas and pulmonary nonsquamous cell carcinomas (small cell and large cell carcinomas). In contrast to this result, no reaction was recognized in several normal tissues, such as the lung, stomach, colon, liver, spleen, lymph node, pancreas, kidney, and mammary gland, however, a weak reaction was found in the basal layer of the esophageal mucosa. Antigenetic determinant of squamous cell carcinoma reactive with KYSM-1 was revealed to be protein moiety after enzyme treatment, and molecular weight of the antigen was about 60,000 analysed by Western blotting. These results suggest that KYSM-1 may be useful for not only immunoscintigraphy but also for the targeting chemotherapy.
Monoclonal antibody KYSM-1, whose immunoglobulin was IgM, was produced against human esophageal squamous cell carcinoma (KE-1) which has been maintained by serial subcutaneous transplantation in nude mice. In immunohistochemical reactions with various cancer tissues, KYSM-1 showed a strong reaction specific to squamous cell carcinomas of the esophagus, oral cavity and lung (92%, 95/103 and 100%, 3/3 and 100%, 7/7), with the lack of gastrointestinal adenocarcinomas and pulmonary nonsquamous cell carcinomas (small cell and large cell carcinomas). In contrast to this result, no reaction was recognized in several normal tissues, such as the lung, stomach, colon, liver, spleen, lymph node, pancreas, kidney, and mammary gland, however, a weak reaction was found in the basal layer of the esophageal mucosa. Antigenetic determinant of squamous cell carcinoma reactive with KYSM-1 was revealed to be protein moiety after enzyme treatment, and molecular weight of the antigen was about 60,000 analysed by Western blotting. These results suggest that KYSM-1 may be useful for not only immunoscintigraphy but also for the targeting chemotherapy.
Related Concept Videos
Mitogens and the Cell Cycle
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Esophageal Achalasia

